Press "esc" to clear
Go to Advanced Search

Showing results

110 of 3323

Article ID: 705112

Oxybutynin lessens hot flash frequency, improves breast cancer survivor quality of life, Mayo-led study finds

Mayo Clinic

Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors.

Released:
7-Dec-2018 10:05 AM EST
  • Embargo expired:
    6-Dec-2018 4:15 PM EST

Article ID: 704903

Black Breast Cancer Patients Have Worse Outcomes than Whites, Even With Similar Treatments

Loyola University Health System

Black women with the most common form of early breast cancer had worse outcomes than white women even after receiving equivalent care, according to a major new study led by Loyola Medicine medical oncologist Kathy Albain, MD. Dr. Albain presented findings at the San Antonio Breast Cancer Symposium.

Released:
4-Dec-2018 2:25 PM EST

Article ID: 705006

Radiation therapy’s pivotal role in treating breast cancer featured at SABCS 2018

American Society for Radiation Oncology (ASTRO)

This year’s San Antonio Breast Cancer Symposium (SABCS) features a record number of radiation oncology trials among its oral presentations. Today’s General Session 4 (3:15-5:00 p.m. CT in Hall 3) will showcase five major studies designed to improve outcomes for the majority of breast cancer patients who receive radiation therapy to cure and/or provide relief from the disease.

Released:
6-Dec-2018 9:30 AM EST
  • Embargo expired:
    5-Dec-2018 6:10 PM EST

Article ID: 704124

Is Our Nation’s Water Supply Disrupting the Human Endocrine System?

Society for Risk Analysis (SRA)

Exposure to emerging contaminants, even at extremely low doses, can cause adverse health effects for humans, including endocrine disruption which can lead to developmental malformations, interference with reproduction, increased cancer risk and disturbances in the immune and nervous system functions. These emerging contaminants include pharmaceuticals and personal care products, hormones, perfluorinated alkyls and volatile organics, and they may pose a threat to both the environment and human health.

Released:
16-Nov-2018 10:05 AM EST

Article ID: 705016

Investigadores da Mayo: apixabana oral segura, eficaz no tratamento de coágulos sanguíneos em pacientes com câncer

Mayo Clinic

Os investigadores da Mayo Clinic constataram que um medicamento oral, apixabana, utilizado para tratar a formação de coágulos de sangue em pacientes submetidos a terapia contra o câncer, é seguro e eficaz. O medicamento foi associado a uma menor quantidade de complicações hemorrágicas e menos formação recorrente de coágulos sanguíneos, em comparação com a heparina de baixo peso molecular. Os resultados foram apresentadas na assembleia anual da Sociedade Americana de Hematologia por Robert McBane II M.D., um cardiologista da Mayo Clinic.

Released:
5-Dec-2018 5:05 PM EST

Article ID: 705017

Investigadores da Mayo Clinic identificam novas estratégias que podem melhorar a terapia com células T CAR

Mayo Clinic

Investigadores da Mayo Clinic desenvolveram duas novas estratégias que podem melhorar o desempenho da terapia do receptor de antígeno quimérico (terapia com células T CAR) no tratamento do câncer. Eles apresentarão os resultados de suas pesquisas pré-clínicas na assembleia anual de 2018 da Sociedade Americana de Hematologia em San Diego, EUA.

Released:
5-Dec-2018 5:05 PM EST
  • Embargo expired:
    5-Dec-2018 4:00 PM EST

Article ID: 703885

Human Exposures and Health Effects Associated with Unconventional Oil and Gas Development

Society for Risk Analysis (SRA)

The Health Effects Institute (HEI) convened an Energy Research Committee to help ensure the protection of public health during such development. A symposium at the 2018 Society for Risk Analysis (SRA) Annual Meeting will summarize the Committee’s review approach and preliminary findings and provide initial options for future research intended to fill knowledge gaps.

Released:
13-Nov-2018 10:00 AM EST
  • Embargo expired:
    5-Dec-2018 4:00 PM EST

Article ID: 704118

Being Employed Puts Your Health at Risk

Society for Risk Analysis (SRA)

The symposium presentation at the Society for Risk Analysis (SRA) Annual Meeting will review current topics in occupational risk analysis that health officials are currently challenged with, including chronic traumatic encephalopathy (CTE) in football and exposure to metals via dermal contact in the workplace.

Released:
16-Nov-2018 10:05 AM EST

Article ID: 704947

Científicos de Mayo Clinic identifican nuevas estrategias para mejorar terapia de células T con receptor de antígeno quimérico

Mayo Clinic

Los científicos de Mayo Clinic desarrollaron dos estrategias nuevas que podrían mejorar el rendimiento de la terapia de células T con receptor de antígeno quimérico en el tratamiento del cáncer.

Released:
5-Dec-2018 10:05 AM EST

Showing results

110 of 3323

Chat now!